Zobrazeno 1 - 2
of 2
pro vyhledávání: '"I. Aranguren Ruiz"'
Autor:
M I, Aranguren-Ruiz, M V, Acha-Arrieta, J M, Casas-Fernández de Tejerina, M, Arteaga-Mazuelas, V, Jarne-Betrán, R, Arnáez-Solis
Publikováno v:
Revista espanola de cirugia ortopedica y traumatologia. 61(3)
To evaluate, from a clinical perspective, and with easily identifiable variables, those factors that influence the survival of patients admitted to a care unit designed for the comprehensive treatment of patients with hip fracture after being surgica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6f63c5a4cdd34ce0afdf090be11255da
https://pubmed.ncbi.nlm.nih.gov/28363666
https://pubmed.ncbi.nlm.nih.gov/28363666
Autor:
P. Martín Andrés, MJ Gayan Lera, L Gómez de Segura Iriarte, P Carmona Oyaga, L Leunda Eizmendi, E. Esnaola Barrena, J Barral Juez, A Asensio Bermejo, P Pascual Gonzalez, I. Aranguren Ruiz
Publikováno v:
European Journal of Hospital Pharmacy. 19:112.3-113
Background It is necessary to monitor the effect of erythropoietin (EPO) on haemoglobin (Hb) levels to check the efficacy and safety of the medicine. The desirable therapeutic range of Hb according to the product information is from 10 to 12 g/dl and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dd2ce1716d2c8aa8dd1fcc1249af3323
https://doi.org/10.1136/ejhpharm-2012-000074.73
https://doi.org/10.1136/ejhpharm-2012-000074.73